FDA panel says Allos Therapeutics drug will benefit patients with rare form of lymphoma

FDA panel backs Allos Therapeutics’ cancer drug

WASHINGTON — Federal health experts voted Wednesday in favor of an experimental cancer drug from Allos Therapeutics for patients with a rare form of cancer.

Hologic says FDA cleared more flexible design of MammoSite radiation seeding system

Hologic: FDA approves new radiation therapy system

BEDFORD, Mass. — Hologic Inc. said the Food and Drug Administration approved a new version of its MammoSite system, which delivers radiation seeds to prevent recurrences of breast cancer.

FDA panel says Genzyme did not conduct study necessary to prove benefit of leukemia drug

FDA panel wants more data on Genzyme cancer drug

WASHINGTON — A panel of cancer experts has issued a negative review of a leukemia drug from Genzyme, saying more data is needed to establish its safety and efficacy for older patients.

Watson Pharmaceuticals gets FDA approval for over-the-counter emergency contraceptive

Watson gets approval for emergency contraceptive

CORONA, Calif. — Watson Pharmaceuticals Inc. said Friday it received Food and Drug Administration approval for its over-the-counter version of the emergency contraceptive Plan B, which is made by Barr Pharmaceuticals unit Duramed.

FDA cites shortcomings with Genzyme study of leukemia drug for frail, elderly patients

FDA: problems with Genzyme study of leukemia drug

WASHINGTON — Federal regulators on Friday questioned whether Genzyme’s leukemia drug Clolar should be approved for older patients based on limited studies conducted by the biotech drugmaker.

Protected by Comment Guard Pro